XANDO
DÍAZ VILLAMARÍN
DOCENTE INVITADO
Karolinska Institute
Estocolmo, SueciaPublikationen in Zusammenarbeit mit Forschern von Karolinska Institute (2)
2023
-
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
The Lancet, Vol. 401, Núm. 10374, pp. 347-356